Pirarubicin is taken up by a uridine-transportable sodium-dependent concentrative nucleoside transporter in Ehrlich ascites carcinoma cells

Cancer Chemotherapy and Pharmacology

Volumn 51, Issue 6, 2003, Pages 512-518

  Nagai, Katsuhito ^a   Nagasawa, Kazuki ^a   Ishimoto, Atsushi ^a   Fujimoto, Sadaki ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Anthracycline; Ehrlich cell; Molecular target; Nucleoside transporter; Transport

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CARRIER PROTEIN; CONCENTRATIVE NUCLEOSIDE TRANSPORTER; CONCENTRATIVE NUCLEOSIDE TRANSPORTER 2; CONCENTRATIVE NUCLEOSIDE TRANSPORTER 3; DOXORUBICIN; EQUILIBRATIVE NUCLEOSIDE COTRANSPORTER; FORMYCIN B; ISOPROTEIN; LIGAND; MESSENGER RNA; NITROBENZYLTHIOGUANOSINE; NITROBENZYLTHIOINOSINE; NUCLEOSIDE TRANSPORTER; PIRARUBICIN; PROTEIN INHIBITOR; SODIUM ION; UNCLASSIFIED DRUG; URIDINE;

ADOLESCENT; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG TARGETING; DRUG TRANSPORT; DRUG UPTAKE; EHRLICH ASCITES TUMOR CELL; MALE; MOLECULAR TARGET; MOLECULE; MOUSE; NONHUMAN; NUCLEOSIDE TRANSPORT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0038051355     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-003-0569-0     Document Type: Article

References (29)

1. Barcelo F, Barcelo I, Gavilanes F, Ferragut JA, Yanovich S, Gonzalez-Ros JM (1986) Interaction of anthracyclines with nucleotides and related compounds studied by spectroscopy. Biochim Biophys Acta 884:172
2. Barthelemy-Clavey V, Maurizot JC, Dimicoli JL, Sicard P (1974) Self-association of daunorubicin. FEBS Lett 46:5
3. Blum RH, Carter SK (1974) Adriamycin. A new anticancer drug with significant clinical activity. Ann Intern Med 80:249
4. +-dependent and -independent nucleoside transporters of Ehrlich ascites tumor cells. J Pharmacol Exp Ther 286:1333
5. Cass CE, Young JD, Baldwin SA (1998) Recent advances in the molecular biology of nucleoside transporters of mammalian cells. Biochem Cell Biol 76:761
6. Chaires JB, Dattagupta N, Crothers DM (1982) Studies on interaction of anthracycline antibiotics and deoxyribonucleic acid: equilibrium binding studies on interaction of daunomycin with deoxyribonucleic acid. Biochemistry 21:3933
7. Dalmark M (1981) Characteristics of doxorubicin transport in human red blood cells. Scand J Clin Lab Invest 41:633
8. Dalmark M, Johansen P (1982) Molecular association between doxorubicin (adriamycin) and DNA-derived bases, nucleosides, nucleotides, other aromatic compounds, and proteins in aqueous solution. Mol Pharmacol 22:158
9. Dalmark M, Storm HH (1981) A Fickian diffusion transport process with features of transport catalysis. Doxorubicin transport in human red blood cells. J Gen Physiol 78:349
10. Eksborg S (1978) Extraction of daunorubicin and doxorubicin and their hydroxyl metabolites: self-association in aqueous solution. J Pharm Sci 67:782
11. Griffith DA, Jarvis SM (1996) Nucleoside and nucleobase transport systems of mammalian cells. Biochim Biophys Acta 1286:153
12. Hammond JR (1991) Comparative pharmacology of the nitrobenzylthioguanosine-sensitive and -resistant nucleoside transport mechanisms of Ehrlich ascites tumor cells. J Pharmacol Exp Ther 259:799
13. 3H]nitrobenzylthioinosine binding site. Mol Pharmacol 39:771
14. 3H]guanosine by nucleoside transporter subtypes in Ehrlich ascites tumour cells. Biochem J 287:431
15. Nagai K, Nagasawa K, Sadzuka Y, Tsujimoto M, Takara K, Ohnishi N, Yokoyama T, Fujimoto S (2002) Relationships between the in vitro cytotoxicity and transport characteristics of pirarubicin and doxorubicin in M5076 ovarian sarcoma, and comparison with those in Ehrlich ascites carcinoma cells. Cancer Chemother Pharmacol 49:244
16. Nagasawa K, Natazuka T, Chihara K, Kitazawa F, Tsumura A, Takara K, Nomiyama M, Ohnishi N, Yokoyama T (1996) Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of pirarubicin in HL60 and pirarubicin-resistant HL60 cells. Cancer Chemother Pharmacol 37:297
17. Nagasawa K, Ohnishi N, Yokoyama T (1998) Possibility of contribution of nucleoside transport systems to pirarubicin uptake by HL60 cells but not mononuclear cells. Jpn J Cancer Res 89:673
18. Nagasawa K, Nagai K, Ohnishi N, Yokoyama T, Fujimoto S (2001) Contribution of specific transport systems to anthracycline transport in tumor and normal cells. Curr Drug Metab 2:355
19. Pennycooke M, Chaudary N, Shuralyova I, Zhang Y, Coe IR (2001) Differential expression of human nucleoside transporters in normal and tumor tissue. Biochem Biophys Res Commun 280:951
20. +-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib). J Biol Chem 276:2914
21. Sasaya M, Wada I, Shida M, Sato M, Hatakeyama Y, Saitoh H, Takada M (1998) Uptake of doxorubicin by cultured kidney epithelial cells LLC-PK1. Biol Pharm Bull 21:527
22. Skovsgaard T (1977) Transport and binding of daunorubicin, adriamycin, and rubidazone in Ehrlich ascites tumour cells. Biochem Pharmacol 26:215
23. Skovsgaard T (1978) Carrier-mediated transport of daunorubicin, adriamycin, and rubidazone in Ehrlich ascites tumour cells. Biochem Pharmacol 27:1221
24. Skovsgaard T (1978) Mechanisms of resistance to daunorubicin in Ehrlich ascites tumor cells. Cancer Res 38:1785
25. Skovsgaard T (1978) Mechanism of cross-resistance between vincristine and daunorubicin in Ehrlich ascites tumor cells. Cancer Res 38:4722
26. Slapak CA, Lecerf JM, Daniel JC, Levy SB (1992) Energy-dependent accumulation of daunorubicin into subcellular compartments of human leukemia cells and cytoplasts. J Biol Chem 267:10638
27. Takeda M, Khamdang S, Narikawa S, Kimura H, Kobayashi Y, Yamamoto T, Cha SH, Sekine T, Endou H (2002) Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J Pharmacol Exp Ther 300:918
28. Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y (1982) 4′-O-Tetrahydropyranyladriamycin as a potential new antitumor agent. Cancer Res 42:1462
29. Yao SYM, Cass CE, Young JD (1996) Transport of the antiviral nucleoside analogs 3′-azido-3′-deoxythymidine and 2′,3′-dideoxycytidine by a recombinant nucleoside transporter (rCNT) expressed in Xenopus laevis oocytes. Mol Pharmacol 50:388